Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More

Summary

Erasca stock has increased 715%, and a biotech fund purchased an additional $68 million of the company's shares. The article provides headline information about fund activity and stock performance without disclosing specific clinical or regulatory catalysts.